Skip to main content

Application Notes Cell avidity

Part of: Knowledge repository

Application notes

Read our latest application notes on your topic of interest

Cell avidity measurement: a new accurate method to predict in vivo CAR T cell efficacy and minimize drug discovery timelines

Dr. Marcela Maus Associate Professor at Harvard Medical School and Director of Cellular Immunotherapy at Massachusetts General Hospital
Download now

Increased cell avidity through CD38 co-receptor drives enhanced BCMA CAR T-cell sensitivity and persistence in multiple myeloma

Dr. Maria Themeli Group Leader of Hematology Department at Amsterdam UMC Cancer Center Amsterdam
Download now

Identify functionally optimal TCR-engineered T cells through cell avidity measurements

Dr. Natalie Rufer Associate Professor at University of Lausanne
Download now

Rapid assessment of CAR T-cell therapy strategies for multiple myeloma with the cell avidity analysis

Prof. Carlos Fernandez de Larrea Associate Professor of Medicine at University of Barcelona
Download now
Close Menu

For pricing, reach out to your application scientist or account manager

Open Email

Fill in our contact form, we will reach out to you!

Please include ‘Lakeview data analysis price inquiry’ in the Message box

Contact Us


Join our newsletter

Get exclusive news on the latest publications, product developments, events and breakthrough science.

By submitting the form you agree to LUMICKS' privacy policy. You can revoke your consent at any time.

Download our webinar recording:

 

Download our Cell Therapy (CAR-T, TCR, NK) applications deck